Skip to main navigation Skip to search Skip to main content

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial

  • L Newby
  • , Michael Marber
  • , Chiara Melloni
  • , Lea Sarov-Blat
  • , Laura Aberle
  • , Philip Aylward
  • , Gengqian Cai
  • , Robbert De Winter
  • , Christian Hamm
  • , John Heitner
  • , Raymond Kim
  • , Amir Lerman
  • , Manesh Patel
  • , Jean-François Tanguay
  • , John Lepore
  • , Hussein Al-Khalidi
  • , Dennis Sprecher
  • , Christopher Granger

    Research output: Contribution to journalArticlepeer-review

    142 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial'. Together they form a unique fingerprint.
    Sort by

    Pharmacology, Toxicology and Pharmaceutical Science